Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications
about
Sperm-associated antigen 1 is expressed early in pancreatic tumorigenesis and promotes motility of cancer cellsWhat's the place of immunotherapy in malignant mesothelioma treatments?CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells.Targeting the epigenome in malignant pleural mesotheliomaThe SSX family of cancer-testis antigens as target proteins for tumor therapy.MOK overexpression is associated with promoter hypomethylation in patients with acute myeloid leukemia.Dissecting the first transcriptional divergence during human embryonic development.A potential role for epigenetic modulatory drugs in the enhancement of cancer/germ-line antigen vaccine efficacy.Treatment with 5-Aza-2'-Deoxycytidine Induces Expression of NY-ESO-1 and Facilitates Cytotoxic T Lymphocyte-Mediated Tumor Cell Killing.Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1.The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward.Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy.Semenogelin I expression in myeloma cells can be upregulated pharmacologically.An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members.Identification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cellsThe biology of cancer testis antigens: putative function, regulation and therapeutic potentialImproving cancer immunotherapy with DNA methyltransferase inhibitors.Anti-CTLA-4 therapy for malignant mesothelioma.HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression.Downregulation of MUC1 expression and its recognition by CD8⁺ T cells on the surface of malignant pleural mesothelioma cells treated with HDACi.Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications.In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects.Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells.Epigenomic stress response. Knockdown of DNA methyltransferase 1 triggers an intra-S-phase arrest of DNA replication and induction of stress response genes.Identification of tumor antigens in malignant mesothelioma.Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma.Epigenetically regulated tumor-associated antigens in melanoma
P2860
Q24303925-5F998D6F-4FB5-4409-A217-EB8BE44F8EF0Q33781142-C6EBBA2B-8D95-41FB-B9B3-F82BA349E946Q33784789-12488886-BE88-4971-A5D4-A01636C1AE6BQ33890546-55CDF75D-BD49-4A42-8622-5A5098D34A23Q34146229-050A6F83-3E55-4F90-906E-A76C9EEEBA86Q35144877-C4390AD8-C3D0-44C2-964B-DB7C51DA9190Q35775598-0B25396C-24AD-41EA-ACEF-964694C149ABQ35968482-D1A59D46-506D-475F-9CA6-C42C4988BC83Q36136992-7F4AB89F-5EBF-49B1-A0B5-24D6A5D22D21Q36471827-60D15F0F-51E7-4A90-B027-31E84A58CDC4Q36509433-DA0DA001-94AA-4B87-A012-09F7DD0F183EQ36614408-3E0602D4-3977-4059-8E19-4159FA6AA97DQ37042374-84FB1394-992D-4F14-A6BD-126DC0734F55Q37052200-F5B1EE77-F8FE-4530-ACA2-3C38CBC204A4Q37225261-9D664FE2-6625-4C2F-93D9-D62A8E2815C0Q37849976-71DEB39A-7258-4BAF-8A6E-47CA85128D61Q38662760-1403BDFB-3874-4B7A-A883-3623EF59F6D5Q39148274-BFAD4DF5-46AD-4ED9-8FFB-66901678D50DQ39211999-D5268B20-D1BC-427C-B696-92B7D3A300F8Q39432616-3379A5B9-996C-4ED6-B67D-59506381B145Q39500230-4C1E8BFB-CBC6-45F9-84FD-F0175FBBB3F3Q39718655-91296A03-0CB2-4024-8E6F-9A0D9B2290FAQ40568933-30D6BC46-7A55-4870-BAEA-1AD140E85F85Q40671720-4BD0D1EB-A763-4706-92A3-499B947AD8F1Q45238421-0EDCFAF9-9141-4B63-83B8-D95238CAE092Q55447998-0E752B74-CC81-437F-923B-44D213E5722BQ57570339-ECEFDB6F-CDB1-47E9-9381-650C77F4A90A
P2860
Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Cancer testis antigens express ...... immunotherapeutic implications
@ast
Cancer testis antigens express ...... immunotherapeutic implications
@en
type
label
Cancer testis antigens express ...... immunotherapeutic implications
@ast
Cancer testis antigens express ...... immunotherapeutic implications
@en
prefLabel
Cancer testis antigens express ...... immunotherapeutic implications
@ast
Cancer testis antigens express ...... immunotherapeutic implications
@en
P2093
P2860
P356
P1476
Cancer testis antigens express ...... immunotherapeutic implications
@en
P2093
A Jungbluth
E Maraskovsky
L Sigalotti
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600174
P407
P577
2002-03-01T00:00:00Z